EG621697 Inhibitors
Rpl32l, a ribosomal protein L32-like, is an essential component of the ribosome, contributing to the structural integrity and function of this cellular machinery responsible for protein synthesis. As a constituent of the large ribosomal subunit, Rpl32l participates in the translation of mRNA into polypeptides, playing a crucial role in cellular homeostasis and growth. Inhibition of Rpl32l involves targeting various stages of protein synthesis, with chemical inhibitors disrupting ribosomal function and assembly. Compounds such as Rapamycin, Anisomycin, and Actinomycin D directly impact the ribosome, leading to reduced synthesis of Rpl32l and other ribosomal proteins. Additionally, indirect inhibitors like Cisplatin and Homoharringtonine exert their effects by causing DNA damage and activating cellular stress responses, ultimately inhibiting ribosomal biogenesis and Rpl32l synthesis.
The general mechanisms of inhibition highlight the importance of Rpl32l in protein synthesis and cellular processes. Targeting ribosomal function represents a strategy to modulate Rpl32l levels and activity, providing insights into the intricate regulation of gene expression at the translational level. Understanding these mechanisms contributes to the development of tools for investigating cellular processes and potential avenues for interventions in diseases involving dysregulation of protein synthesis.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits the mTOR pathway, disrupting protein synthesis and indirectly impacting Rpl32l, a component of the ribosome. Its action on mTOR prevents the assembly of functional ribosomes, leading to a reduction in Rpl32l-containing ribosomal complexes and suppressing overall protein translation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin inhibits protein synthesis by binding to the 60S ribosomal subunit. Its direct impact on ribosomal function disrupts the assembly and stability of ribosomes containing Rpl32l, leading to a decrease in functional ribosomes and an indirect inhibition of Rpl32l-mediated cellular processes. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D intercalates into DNA and inhibits RNA synthesis. Its action on transcription indirectly influences Rpl32l, as reduced RNA levels lead to decreased availability of mRNA for translation, affecting the synthesis of ribosomal components, including Rpl32l. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide inhibits protein synthesis by preventing peptidyl transferase activity in the ribosome. Its direct impact on ribosomal function results in decreased synthesis of Rpl32l and other ribosomal proteins, leading to an overall inhibition of ribosomal function and protein translation. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $42.00 $214.00 $832.00 $66.00 | 394 | |
Puromycin incorporates into growing polypeptide chains, leading to premature termination of translation. Its action on ribosomes directly affects Rpl32l synthesis, causing incomplete ribosomal complexes and inhibiting the translation of mRNA into functional Rpl32l-containing ribosomes. | ||||||
Hygromycin B solution | 31282-04-9 | sc-29067 | 1 g | $104.00 | 40 | |
Hygromycin B inhibits protein synthesis by interfering with translocation on the ribosome. Its direct impact on ribosomal function disrupts the translation of Rpl32l and other ribosomal proteins, leading to a decrease in the overall synthesis of functional ribosomes containing Rpl32l. | ||||||
Chloramphenicol | 56-75-7 | sc-3594 | 25 g | $90.00 | 10 | |
Chloramphenicol inhibits peptidyl transferase activity in the ribosome, affecting protein synthesis. Its direct impact on ribosomal function leads to reduced synthesis of Rpl32l and other ribosomal proteins, ultimately inhibiting the assembly of functional ribosomes containing Rpl32l. | ||||||
Fusidic acid | 6990-06-3 | sc-215065 | 1 g | $292.00 | ||
Fusidic acid inhibits bacterial translation by preventing EF-G-mediated translocation. While primarily affecting prokaryotic ribosomes, its indirect impact on eukaryotic translation may influence Rpl32l synthesis by disrupting general ribosomal function and protein translation within the cell. | ||||||
Blasticidin S Hydrochloride | 3513-03-9 | sc-204655A sc-204655 | 25 mg 100 mg | $367.00 $520.00 | 20 | |
Blasticidin S inhibits protein synthesis by causing premature chain termination during translation. Its direct impact on ribosomal function affects the synthesis of Rpl32l and other ribosomal proteins, leading to a decrease in the overall assembly of functional ribosomes containing Rpl32l. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin forms DNA adducts, causing DNA damage and indirectly impacting Rpl32l. Its genotoxic effects activate cellular stress responses, including inhibition of ribosomal biogenesis, leading to a decrease in the synthesis of Rpl32l and other ribosomal components. | ||||||